Development of an experimental diet model in rats to study hyperlipidemia and insulin resistance, markers for coronary heart disease
Open Access
- 1 January 2014
- journal article
- research article
- Published by Medknow in Indian Journal of Pharmacology
- Vol. 46 (3), 270-6
- https://doi.org/10.4103/0253-7613.132156
Abstract
Objectives: The objective of this study is to develop an experimental model of hyperlipidemia and insulin resistance (IR), markers of coronary heart disease (CHD) using high fat and high sugar (HFHS) diet and to evaluate the efficacy of the model using atorvastatin, a known antihyperlipidemic drug, pioglitazone, a known insulin sensitizer, and Tinospora cordifolia (Tc), an antidiabetic plant. Materials and Methods: Following Institutional Animal Ethics Committee permission, the study was conducted in male Wistar rats (200-270 g). The model was developed using a high fat (vanaspati ghee: coconut oil, 3:1) oral diet along with 25% fructose (high sugar) added in drinking water over a period of 6 weeks. Atorvastatin (2.1 mg/kg/day), pioglitazone (2.7 mg/kg/day) and Tc (200 mg/kg/day) were administered 3 weeks after initiation of HFHS diet and continued for another 3 weeks. Parameters assessed were weight, lipid profile, fasting blood glucose, insulin, and gastric emptying. Serum malondialdehyde (MDA) and catalase were assessed as markers of oxidative stress. Results: Administration of HFHS diet demonstrated a significant increase in blood glucose, insulin, total and low density lipoprotein cholesterol and triglycerides with a decrease in high density lipoprotein cholesterol. Treatment with test drugs decreased blood sugar, insulin, lipid parameters, increased gastric emptying rate, decreased MDA levels, and catalase activity when compared to HFHS diet group, confirming the efficacy of the model. Atherogenic index of all the test drugs (0.48, 0.57, and 0.53) was significantly lower as compared to HFHS diet group (1.107). Conclusion: This study confirms the development of a diet based cost-effective and time efficient experimental model, which can be used to study two important markers of cardiovascular disease that is, hyperlipidemia and IR and to explore the efficacy of new molecules in CHD.Keywords
This publication has 19 references indexed in Scilit:
- Gastrodia elata Blume water extracts improve insulin resistance by decreasing body fat in diet-induced obese rats: vanillin and 4-hydroxybenzaldehyde are the bioactive candidatesEuropean Journal of Nutrition, 2010
- Oxidative Stress and Antioxidant Defense Mechanisms Linked to Exercise During Cardiopulmonary and Metabolic DisordersOxidative Medicine and Cellular Longevity, 2009
- Animal models in type 2 diabetes research: an overview.2007
- Development of Wistar rat model of insulin resistanceWorld Journal of Gastroenterology, 2005
- Fructose, weight gain, and the insulin resistance syndrome,,The American Journal of Clinical Nutrition, 2002
- Evidence-based management of dyslipidaemiaThe Lancet, 1995
- Cholesterol lowering and mortality: the importance of considering initial level of risk.BMJ, 1993
- Influence of Dietary Fat Composition on Development of Insulin Resistance in Rats: Relationship to Muscle Triglyceride and ω-3 Fatty Acids in Muscle PhospholipidDiabetes, 1991
- Lipid screening: is it enough to measure total cholesterol concentration?BMJ, 1990
- Role of Insulin Resistance in Human DiseaseDiabetes, 1988